DV
Dividend Vision

CELC — Celcuity Inc.

Celcuity Inc. (CELC)

Total return is 543.8% over the past 8.9 years, 288.3 points ahead of SPY at 255.5%. Its deepest 1-year drawdown was 43.3%.

CELC is an equity stock that operates in the biotechnology sector, focusing on personalized cancer diagnostics and treatment selection. The fund currently does not provide dividend distributions, making it unsuitable for income-focused investors seeking regular payouts. This equity holding may appeal primarily to growth-oriented investors seeking exposure to precision medicine and oncology innovation rather than current income generation.

CELC key facts

Asset type
Stock
Asset class
Equity
Inception date
09/20/2017
Distribution frequency
None
Last close
$92.00
Market cap
$4,501,735,424
Average volume
1333600.0
Beta
0.2
Payout ratio
0.0
Forward P/E
0.0
EPS
$-4.30